The global Generic Drugs Market is valued at USD 487.21 Billion in 2024 and is projected to reach a value of USD 898 Billion ...

Several new weight loss drugs are undergoing trials in the UK. These drugs will work similarly to those already available but ...

Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...

Takeda, coming off a high of 2024 growth, is pushing through what it says will be the worst of its Vyvanse-related declines.

Trump is changing Medicare, mostly focusing on providers. But the biggest impact may come from tariffs and deporting ...

Medicare may cover Skyrizi (risankizumab-rzaa) if you have a plan with prescription drug benefits. Learn more.

Medicare may cover Ubrelvy (ubrogepant) if you have a plan with prescription drug coverage, such as a Part D plan or a Medicare Advantage (Part C) plan. Ubrelvy is a brand-name drug that doctors may ...

As glyphosate travels through the plant, the poison stops a specific reaction in the plant’s metabolism, and the plant ...

Civil society groups and health experts say the trade Agreement threatens to erode long-standing protections that allow India to produce low-cost generic drugs. | ITV National News ...

Nokia’s latest enforcement actions against Geely and Transsion joining Via LA’s AAC pool were also among the top talking ...

US pharma firms face higher drug costs, delayed launches, and compliance risks from proposed sectoral tariffs, prompting urgent supply chain reviews.

The tablets will be produced at Zydus’ manufacturing site in Ahmedabad, Gujarat. Citing IQVIA data from May 2025, the company ...